| Literature DB >> 32787634 |
Diego Castillo-Barnes1, Francisco J Martinez-Murcia2, Andres Ortiz2, Diego Salas-Gonzalez1, Javier RamÍrez1, Juan M Górriz1.
Abstract
Finding new biomarkers to model Parkinson's Disease (PD) is a challenge not only to help discerning between Healthy Control (HC) subjects and patients with potential PD but also as a way to measure quantitatively the loss of dopaminergic neurons mainly concentrated at substantia nigra. Within this context, this work presented here tries to provide a set of imaging features based on morphological characteristics extracted from I[Formula: see text]-Ioflupane SPECT scans to discern between HC and PD participants in a balanced set of [Formula: see text] scans from Parkinson's Progression Markers Initiative (PPMI) database. These features, obtained from isosurfaces of each scan at different intensity levels, have been classified through the use of classical Machine Learning classifiers such as Support-Vector-Machines (SVM) or Naïve Bayesian and compared with the results obtained using a Multi-Layer Perceptron (MLP). The proposed system, based on a Mann-Whitney-Wilcoxon U-Test for feature selection and the SVM approach, yielded a [Formula: see text] balanced accuracy when the performance was evaluated using a [Formula: see text]-fold cross-validation. This proves the reliability of these biomarkers, especially those related to sphericity, center of mass, number of vertices, 2D-projected perimeter or the 2D-projected eccentricity, among others, but including both internal and external isosurfaces.Entities:
Keywords: Computer-Aided-Diagnosis (CAD); Parkinson’s Progression Markers Initiative (PPMI); Parkinson’s disease; Single Photon Emission Computed Tomography (SPECT); isosurfaces; machine learning; neuroimaging; supervised learning
Mesh:
Year: 2020 PMID: 32787634 DOI: 10.1142/S0129065720500446
Source DB: PubMed Journal: Int J Neural Syst ISSN: 0129-0657 Impact factor: 5.866